Limited resection for the treatment of patients with stage IA lung cancer

Juan P. Wisnivesky, Claudia I. Henschke, Scott Swanson, David F. Yankelevitz, Javier Zulueta, Sue Marcus, Ethan A. Halm

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Objective: Lobectomy is the standard of care for stage IA lung cancer. Some small retrospective studies have suggested similar results after limited resection for tumors ≤2 cm in size. The objective of the study was to compare survival after lobectomy and limited resection among Medicare patients with lung cancer. Methods: Using the Surveillance, Epidemiology, and End Results registry, linked to Medicare records, we identified 1165 cases of stage I lung cancer ≤2 cm in size that underwent lobectomy or limited resection (segmentectomy or wedge resection). We used logistic regression to determine propensity scores for undergoing limited resection based on the patients preoperative characteristics. Overall and lung cancer-specific survival of patients treated with lobectomy or limited resection was compared after adjusting for their propensity score. Results: Overall, 196 (17%) patients underwent limited resection. For the entire sample, the adjusted hazard ratio for all cause mortality (1.09; 95% confidence interval: 0.85-1.40) or lung cancer-specific death (hazard ratio: 1.39; 95% confidence interval: 0.97-2.01) for patients undergoing limited resection were not significantly different from those having lobectomy. Similarly, we found no significant differences in overall or lung cancer-specific survival for patients treated with limited resection compared with lobectomy when data was analyzed stratifying and matching patients by their propensity scores. Conclusions: These results suggest that survival of patients >65 years of age undergoing limited resection or lobectomy for stage IA tumors ≤2 cm appears to be similar. Although these findings should be confirmed in prospective trials, our results suggest that limited resection may be an effective therapeutic alternative for these patients.

Original languageEnglish (US)
Pages (from-to)550-554
Number of pages5
JournalAnnals of Surgery
Volume251
Issue number3
DOIs
StatePublished - Mar 2010

Fingerprint

Lung Neoplasms
Propensity Score
Therapeutics
Survival
Medicare
Confidence Intervals
Segmental Mastectomy
Standard of Care
Registries
Neoplasms
Epidemiology
Retrospective Studies
Logistic Models
Mortality

ASJC Scopus subject areas

  • Surgery

Cite this

Wisnivesky, J. P., Henschke, C. I., Swanson, S., Yankelevitz, D. F., Zulueta, J., Marcus, S., & Halm, E. A. (2010). Limited resection for the treatment of patients with stage IA lung cancer. Annals of Surgery, 251(3), 550-554. https://doi.org/10.1097/SLA.0b013e3181c0e5f3

Limited resection for the treatment of patients with stage IA lung cancer. / Wisnivesky, Juan P.; Henschke, Claudia I.; Swanson, Scott; Yankelevitz, David F.; Zulueta, Javier; Marcus, Sue; Halm, Ethan A.

In: Annals of Surgery, Vol. 251, No. 3, 03.2010, p. 550-554.

Research output: Contribution to journalArticle

Wisnivesky, JP, Henschke, CI, Swanson, S, Yankelevitz, DF, Zulueta, J, Marcus, S & Halm, EA 2010, 'Limited resection for the treatment of patients with stage IA lung cancer', Annals of Surgery, vol. 251, no. 3, pp. 550-554. https://doi.org/10.1097/SLA.0b013e3181c0e5f3
Wisnivesky JP, Henschke CI, Swanson S, Yankelevitz DF, Zulueta J, Marcus S et al. Limited resection for the treatment of patients with stage IA lung cancer. Annals of Surgery. 2010 Mar;251(3):550-554. https://doi.org/10.1097/SLA.0b013e3181c0e5f3
Wisnivesky, Juan P. ; Henschke, Claudia I. ; Swanson, Scott ; Yankelevitz, David F. ; Zulueta, Javier ; Marcus, Sue ; Halm, Ethan A. / Limited resection for the treatment of patients with stage IA lung cancer. In: Annals of Surgery. 2010 ; Vol. 251, No. 3. pp. 550-554.
@article{1935e72842de47e3a64ddec543b3093a,
title = "Limited resection for the treatment of patients with stage IA lung cancer",
abstract = "Objective: Lobectomy is the standard of care for stage IA lung cancer. Some small retrospective studies have suggested similar results after limited resection for tumors ≤2 cm in size. The objective of the study was to compare survival after lobectomy and limited resection among Medicare patients with lung cancer. Methods: Using the Surveillance, Epidemiology, and End Results registry, linked to Medicare records, we identified 1165 cases of stage I lung cancer ≤2 cm in size that underwent lobectomy or limited resection (segmentectomy or wedge resection). We used logistic regression to determine propensity scores for undergoing limited resection based on the patients preoperative characteristics. Overall and lung cancer-specific survival of patients treated with lobectomy or limited resection was compared after adjusting for their propensity score. Results: Overall, 196 (17{\%}) patients underwent limited resection. For the entire sample, the adjusted hazard ratio for all cause mortality (1.09; 95{\%} confidence interval: 0.85-1.40) or lung cancer-specific death (hazard ratio: 1.39; 95{\%} confidence interval: 0.97-2.01) for patients undergoing limited resection were not significantly different from those having lobectomy. Similarly, we found no significant differences in overall or lung cancer-specific survival for patients treated with limited resection compared with lobectomy when data was analyzed stratifying and matching patients by their propensity scores. Conclusions: These results suggest that survival of patients >65 years of age undergoing limited resection or lobectomy for stage IA tumors ≤2 cm appears to be similar. Although these findings should be confirmed in prospective trials, our results suggest that limited resection may be an effective therapeutic alternative for these patients.",
author = "Wisnivesky, {Juan P.} and Henschke, {Claudia I.} and Scott Swanson and Yankelevitz, {David F.} and Javier Zulueta and Sue Marcus and Halm, {Ethan A.}",
year = "2010",
month = "3",
doi = "10.1097/SLA.0b013e3181c0e5f3",
language = "English (US)",
volume = "251",
pages = "550--554",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Limited resection for the treatment of patients with stage IA lung cancer

AU - Wisnivesky, Juan P.

AU - Henschke, Claudia I.

AU - Swanson, Scott

AU - Yankelevitz, David F.

AU - Zulueta, Javier

AU - Marcus, Sue

AU - Halm, Ethan A.

PY - 2010/3

Y1 - 2010/3

N2 - Objective: Lobectomy is the standard of care for stage IA lung cancer. Some small retrospective studies have suggested similar results after limited resection for tumors ≤2 cm in size. The objective of the study was to compare survival after lobectomy and limited resection among Medicare patients with lung cancer. Methods: Using the Surveillance, Epidemiology, and End Results registry, linked to Medicare records, we identified 1165 cases of stage I lung cancer ≤2 cm in size that underwent lobectomy or limited resection (segmentectomy or wedge resection). We used logistic regression to determine propensity scores for undergoing limited resection based on the patients preoperative characteristics. Overall and lung cancer-specific survival of patients treated with lobectomy or limited resection was compared after adjusting for their propensity score. Results: Overall, 196 (17%) patients underwent limited resection. For the entire sample, the adjusted hazard ratio for all cause mortality (1.09; 95% confidence interval: 0.85-1.40) or lung cancer-specific death (hazard ratio: 1.39; 95% confidence interval: 0.97-2.01) for patients undergoing limited resection were not significantly different from those having lobectomy. Similarly, we found no significant differences in overall or lung cancer-specific survival for patients treated with limited resection compared with lobectomy when data was analyzed stratifying and matching patients by their propensity scores. Conclusions: These results suggest that survival of patients >65 years of age undergoing limited resection or lobectomy for stage IA tumors ≤2 cm appears to be similar. Although these findings should be confirmed in prospective trials, our results suggest that limited resection may be an effective therapeutic alternative for these patients.

AB - Objective: Lobectomy is the standard of care for stage IA lung cancer. Some small retrospective studies have suggested similar results after limited resection for tumors ≤2 cm in size. The objective of the study was to compare survival after lobectomy and limited resection among Medicare patients with lung cancer. Methods: Using the Surveillance, Epidemiology, and End Results registry, linked to Medicare records, we identified 1165 cases of stage I lung cancer ≤2 cm in size that underwent lobectomy or limited resection (segmentectomy or wedge resection). We used logistic regression to determine propensity scores for undergoing limited resection based on the patients preoperative characteristics. Overall and lung cancer-specific survival of patients treated with lobectomy or limited resection was compared after adjusting for their propensity score. Results: Overall, 196 (17%) patients underwent limited resection. For the entire sample, the adjusted hazard ratio for all cause mortality (1.09; 95% confidence interval: 0.85-1.40) or lung cancer-specific death (hazard ratio: 1.39; 95% confidence interval: 0.97-2.01) for patients undergoing limited resection were not significantly different from those having lobectomy. Similarly, we found no significant differences in overall or lung cancer-specific survival for patients treated with limited resection compared with lobectomy when data was analyzed stratifying and matching patients by their propensity scores. Conclusions: These results suggest that survival of patients >65 years of age undergoing limited resection or lobectomy for stage IA tumors ≤2 cm appears to be similar. Although these findings should be confirmed in prospective trials, our results suggest that limited resection may be an effective therapeutic alternative for these patients.

UR - http://www.scopus.com/inward/record.url?scp=77649224329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649224329&partnerID=8YFLogxK

U2 - 10.1097/SLA.0b013e3181c0e5f3

DO - 10.1097/SLA.0b013e3181c0e5f3

M3 - Article

C2 - 20160639

AN - SCOPUS:77649224329

VL - 251

SP - 550

EP - 554

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 3

ER -